Fisiopatología e Historia Natural de las Enfermedades Hepáticas y Gastroenterológicas

Virseda-Berdices, A; Martín-Escolano, R; Berenguer, J; González-García, J; Brochado-Kith, O; Rojo, D; Díez, C; Hontañon, V; Pérez-Latorre, L; Ibañez-Samaniego, L; Llop-Herrera, E; Olveira, A; Fernández-Rodríguez, A; Barbas, C; Resino, S; Jimenez-Sousa, MA; ESCORIAL Study Grp.

Metabolomic Changes Associated With the Change in HVPG After DAAs Therapy in HCV Cirrhotic Patients

LIVER INTERNATIONAL. 2025; 45(1): [doi:10.1111/liv.16204]

Ortega Lobete O; Pérez Garvin A; Payeras Otero I; Nogales Rincón Ó.

Digestive pseuodpolyposis as a form of presentation of digestive metastases of primary gastric leiomyosarcoma.

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS. 2025; 117(1): 58-59 [doi:10.17235/reed.2023.9626/2023]

Benedé-Ubieto, R; Cubero, FJ; Nevzorova, YA.

Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)

Gut Microbes. 2024; 16(1): Nº de citas: 72 [doi:10.1080/19490976.2024.2331460]

Gisbert, JP; Donday, MG; Riestra, S; Lucendo, AJ; Benitez, JM; Navarro-Llavat, M; Barrio, J; Morales-Alvarado, VJ; Rivero, M; Busquets, D; Carnerero, EL; Merino, O; Castillejo, ON; Navarro, P; Van Domselaar, M; Gutierrez, A; Alonso-Abreu, I; Mejuto, R; Fernandez-Salazar, L; Iborra, M; Martin-Arranz, MD; Pineda, JR; Sampedro, MJ; Nilsson, KS; Bouhmidi, A; Batista, L; Villafranca, CM; Rodriguez-Lago, I; Ceballos, D; Guerra, I; Manosa, M; Jimenez, IM; Torrella, E; Mendoza, MV; Casanova, MJ; de Francisco, R; Arias-Gonzalez, L; Pedrosa, SM; Garcia-Bosch, O; Garcia-Alonso, FJ; Delgado-Guillena, P; Garcia, MJ; Torrealba, L; Nunez-Ortiz, A; Arregui, MV; Bosca-Watts, MM; Blazquez, I; Acosta, D; Garre, A; Baldan, M; Martinez, C; Acosta, MBD; Domenech, E; Esteve, M; Garcia-Sanchez, V; Nos, P; Panes, J; Chaparro, M.

Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCU

GUT. 2024; 74(3): Nº de citas: 6 [doi:10.1136/gutjnl-2024-333385]

Segura, PS; Gomollón, F; Casas, D; Iborra, M; Vela, M; Fernández-Clotet, A; Muñoz, R; de la Filia, IG; Prada, MG; Rosique, JAF; García, MJ; de Francisco, R; Arias, L; Barrio, J; Guerra, I; Ponferrada, A; Gisbert, JP; Carrillo-Palau, M; Calvet, X; Márquez-Mosquera, L; Gros, B; Cañete, F; Monfort, D; Domínguez, REM; Roncero, O; Laredo, V; Montoro, M; Muñoz, C; López-Cauce, B; Lorente, R; Coronel, AF; Vega, P; Martín, D; Peña, E; Varela, P; Olivares, S; Pajares, R; Lucendo, AJ; Sesé, E; Mateu, BB; Nos, P; Domènech, E; García-López, S.

Psoriasis induced by antiTNF therapy in inflammatory bowel disease: Therapeutic management and evolution of both diseases in a nationwide cohort study

DIGESTIVE AND LIVER DISEASE. 2024; 56(12): 2060-2068 Nº de citas: 1 [doi:10.1016/j.dld.2024.05.021]

Caballero-Marcos, A; Rodríguez-Bachiller, L; Baroja-Mazo, A; Morales, A; Fernández-Cáceres, P; Fernández-Martínez, M; DíazFontenla, F; Velasco, E; Fernández-Yunquera, A; Díaz-Zorita, B; Cortese, S; Pérez-Peña, JM; Colón-Rodríguez, A; Romero-Cristóbal, M; Asencio, JM; Bañares, R; López-Baena, JA; Salcedo-Plaza, M.

Dynamics of Ischemia/Reperfusion Injury Markers During Normothermic Liver Machine Perfusion

Transplantation Direct. 2024; 10(12): Nº de citas: 2 [doi:10.1097/TXD.0000000000001728]

Perez-Campuzano, V; Rautou, PE; Marjot, T; Praktiknjo, M; Alvarado-Tapias, E; Turco, L; Ibáñez-Samaniego, L; González-Alayón, C; Puente, A; Llop, E; Simón-Talero, M; álvarez-Navascués, C; Reiberger, T; Verhelst, X; Tellez, L; Bergmann, JB; Orts, L; Grassi, G; Baiges, A; Audrey, P; Trebicka, J; Villanueva, C; Morelli, MC; Murray, S; Meacham, G; Luetgehetmann, M; Wiesch, JSZ; García-Pagán, JC; Barnes, E; Plessier, A; Hernández-Gea, V.

Impact of SARS-CoV-2 vaccination in patients with vascular liver diseases: Observations from a VALDIG multicenter study

Jhep Reports. 2024; 6(12): Nº de citas: 1 [doi:10.1016/j.jhepr.2024.101191]

Sánchez, AR; Tamargo, FGP; Carbonell-Blanco, C; Vazquez-Sequeros, E; Lucas, D.

Double-snare resection technique: a new approach for treating rectal carcinoid tumors

ENDOSCOPY. 2024; 56: 454-455 Nº de citas: 1 [doi:10.1055/a-2318-2645]

Hionides-Gutierrez, A; Goikoetxea-Usandizaga, N; Sanz-Garcia, C; Martinez-Chantar, ML; Cubero, FJ.

Novel Emerging Mechanisms in Acetaminophen (APAP) Hepatotoxicity

LIVER INTERNATIONAL. 2024; 45(4): Nº de citas: 4 [doi:10.1111/liv.16167]

Islam AH; Díaz LA; Idalsoaga F; Guizzetti L; Mortuza R; Dunn W; Singal AK; Simonetto D; Ramirez-Cadiz C; Zhang W; Qian S; Cabezas J; Sarin SK; Maiwall R; Jalal PK; Higuera-De La Tijera F; Skladany L; Bystrianska N; Rincon D; Chacko KR; Ventura Cots M; Garcia-Tsao G; Abraldes JG; Kamath PS; Arrese M; Shah V; Bataller R; Arab JP.

Comparative effectiveness of different corticosteroid regimens in severe alcohol-associated hepatitis.

Hepatology Communications. 2024; 8(11): [doi:10.1097/HC9.0000000000000573]

Gargallo-Puyuelo CJ; Ricart E; Iglesias E; de Francisco R; Gisbert JP; Taxonera C; Mañosa M; Aguas Peris M; Navarrete-Muñoz EM; Sanahuja A; Guardiola J; Mesonero F; Rivero Tirado M; Barrio J; Vera Mendoza I; de Castro Parga L; García-Planella E; Calvet X; Martín Arranz MD; García S; Sicilia B; Carpio D; Domenech E; Gomollón F.

Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2024; 22(11): 2280-2290 Nº de citas: 6 [doi:10.1016/j.cgh.2024.05.013]

Casanova, MJ; Caballol, B; García, MJ; Mesonero, F; de Célix, CR; Suárez-Alvarez, P; Ferreiro-Iglesias, R; Martín-Rodríguez, MDM; de Francisco, R; Varela-Trastoy, P; Bastida, G; Carrillo-Palau, M; Núñez-Ortiz, A; Ramírez-de la Piscina, P; Ceballos, D; Hervías-Cruz, D; Muñoz-Pérez, R; Velayos, B; Bermejo, F; Busquets, D; Cabacino, M; Camo-Monterde, P; Marín-Jiménez, I; Muñoz, C; de la Peña-Negro, LC; Sierra-Moros, E; Barrio, J; Brunet-Mas, E; Bujanda, L; Cañete, F; Gomollón, F; Manceñido-Marcos, N; Rodríguez-Lago, I; Rodríguez-Grau, MC; Sicilia, B; Torra-Alsina, S; Arranz-Hernández, L; Carpio, D; García-Sepulcre, MF; González-Muñoza, C; Huguet, JM; Márquez-Mosquera, L; López-Serrano, MP; Ponferrada-Díaz, A; Chaparro, M; Gisbert, JP.

Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU

DIGESTIVE AND LIVER DISEASE. 2024; 56(11): 1845-1853 Nº de citas: 4 [doi:10.1016/j.dld.2024.05.009]

Cortese, S; Plua, K; Perez-Alonso, AJ; Hontoria, MS; Pacheco, D; Carroll, NZ; Gómez, MAB; Pena, JMP; Taboada, AGM; Martinez, MF; Kakauridze, SH; Matilla, AM; Baena, JAL; Asencio, JM.

Internal and external validation of indocyanine green plasma disappearance rate to discard liver grafts before procurement

Annals Of Hepato-Biliary-Pancreatic Surgery. 2024; 28(4): 458-465 [doi:10.14701/ahbps.24-086]

Paternostro, R; Kwanten, WJ; Hofer, BS; Semmler, G; Bagdadi, A; Luzko, I; Hernández-Gea, V; Graupera, I; García-Pagán, JC; Saltini, D; Indulti, F; Schepis, F; Moga, L; Rautou, PE; Llop, E; Téllez, L; Albillos, A; Fortea, JI; Puente, A; Tosetti, G; Primignani, M; Zipprich, A; Vuille-Lessard, E; Berzigotti, A; Taru, MG; Taru, V; Procopet, B; Jansen, C; Praktiknjo, M; Gu, WY; Trebicka, J; Ibanez-Samaniego, L; Bañares, R; Rivera-Esteban, J; Pericas, JM; Genesca, J; Alvarado, E; Villanueva, C; Larrue, H; Bureau, C; Laleman, W; Ardevol, A; Masnou, H; Vanwolleghem, T; Trauner, M; Mandorfer, M; Francque, S; Reiberger, T.

Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD

JOURNAL OF HEPATOLOGY. 2024; 81(5): Nº de citas: 21 [doi:10.1016/j.jhep.2024.05.033]

Cornberg, M; Hüppe, D; Sarrazin, C; Ahumada, A; Plaza, FJ; Marino, Z; Otano, JIU; Conway, B; Myles, L; Ramji, A; Abergel, A; Asselah, T; Larrey, D; Aghemo, A; Andreoni, M; Gasbarrini, A; Lampertico, P; Persico, M; Villa, E; Carmiel, M; Chodick, G; Weil, C; Bhagat, A; Bondin, M; Butrymowicz, I; Song, YN; Semizarov, D; Sonparote, S; Llamas, C.

Updated Results from the Retrospective CREST Study on the Safety and Effectiveness of 8-Week Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis

ADVANCES IN THERAPY. 2024; 41(12): 4669-4682 [doi:10.1007/s12325-024-02996-6]

Ricart, E; Bastida, G; Carpio, D; Ceballos, D; Ginard, D; Marín-Jimenéz, I; Menchén, L; Muñoz, F; González-Lama, Y.

Clinical Approach to STRIDE-II in Real-Life Settings: Analysis and Practical Recommendations

Crohns & Colitis 360. 2024; 6(4): Nº de citas: 1 [doi:10.1093/crocol/otae055]

Segovia-Zafra, A; Villanueva-Paz, M; Serras, AS; Matilla-Cabello, G; Bodoque-García, A; Zeo-Sánche, DED; Niu, H; Alvarez-Alvarez, I; Sanz-Villanueva, L; Godec, S; Milisav, I; Bagnaninchi, P; Andrade, RJ; Lucena, MI; Fernández-Checa, JC; Cubero, FJ; Miranda, JP; Nelson, LJ.

Control compounds for preclinical drug-induced liver injury assessment: Consensus-driven systematic review by the ProEuroDILI network

JOURNAL OF HEPATOLOGY. 2024; 81(4): Nº de citas: 9 [doi:10.1016/j.jhep.2024.04.026]

Puente, A; Fortea, JI; Del Pozo, C; Serrano, M; Alonso-Peña, M; Giráldez, A; Tellez, L; Martinez, J; Magaz, M; Ibanez, L; Garcia, J; Llop, E; Alvarez-Navascues, C; Romero, M; Rodriguez, E; Loste, MTA; Antón, A; Echavarria, V; López, C; Albillos, A; Hernández-Gea, V; Garcia-Pagán, JC; Bañares, R; Crespo, J.

Clinical and genetic factors involved in Porto-sinusoidal vascular disorder after oxaliplatin exposure

DIGESTIVE AND LIVER DISEASE. 2024; 56(10): 1721-1729 Nº de citas: 2 [doi:10.1016/j.dld.2024.04.010]